Nonalcoholic fatty liver disease (NAFLD) is a global pandemic that affects one-quarter of the
world's population. NAFLD includes a spectrum of progressive liver disease from steatosis to …

Nonalcoholic fatty liver disease (NAFLD) is a condition characterized by the excessive
accumulation of triglycerides in hepatocytes. NAFLD is the most frequent chronic liver …

Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common cause of
fatal liver diseases such as cirrhosis, liver cancer, and indications for orthotopic liver …

Metabolic dysfunction-associated fatty liver disease (MAFLD) is among the most widespread
metabolic disease globally, and its associated complications including insulin resistance …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and
represents the hepatic expression of several metabolic abnormalities of high epidemiologic …

Non‐alcoholic fatty liver disease (NAFLD) has become a worldwide epidemic over the last
decade. Remarkable progress has been made in understanding the pathogenesis of …

Nonalcoholic fatty liver disease (NAFLD) includes hepatic steatosis, nonalcoholic
steatohepatitis (NASH), fibrosis, and cirrhosis. NAFLD is the most common liver disorder in …

Nonalcoholic fatty liver disease (NAFLD) affects about 30% of the general population in the
United States and includes a spectrum of disease that includes simple steatosis, non …

Nonalcoholic fatty liver disease (NAFLD) describes a spectrum of disorders characterized by
the accumulation of triglycerides within the liver. The global prevalence of NAFLD has been …

NAFLD is a common disease in Western society and ranges from steatosis to steatohepatitis
and to end-stage liver disease. The molecular mechanisms that cause the progression of …